Pioneering research in the use of PROTACs for AD demonstrated the activity of TH006 against the elimination of Tau by recruiting von Hippel–Lindau (VHL) E3 ligase (Ramsay and Di Giovanni, 2017). The gene discussed is MAPT; the disease is Alzheimer disease.